The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems

International Journal of Nanomedicine

Volumn 2, Issue 3, 2007, Pages 315-331

  Haddish Berhane, Nahor ^a   Rickus, Jenna L ^a,b   Haghighi, Kamyar ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Computational chemistry; Computational modelling; Continuum; Multiscale; Oral drug delivery; Stochastic

Indexed keywords

ACRYLIC ACID COPOLYMER; AMINOSALICYLIC ACID DERIVATIVE; MESALAZINE; NANOPARTICLE; NANOSHELL; POLYMER; QUANTUM DOT;

COMPUTER MODEL; CONTROLLED RELEASE FORMULATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SAFETY; DRUG SOLUBILITY; MATHEMATICAL COMPUTING; MOLECULAR DYNAMICS; MONTE CARLO METHOD; NANOTECHNOLOGY; QUANTITATIVE ANALYSIS; REVIEW; STOCHASTIC MODEL; STOMACH PH; TABLET FORMULATION; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; COMPUTER SIMULATION; DRUG CARRIERS; HUMANS; MODELS, CHEMICAL; NANOMEDICINE; NANOSTRUCTURES; PHARMACEUTICAL PREPARATIONS;

EID: 69749115146     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Agoram B, Woltosz WS, Bolger BB. 2002. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliver Rev, 50.
2. Aguirre CG, Haghighi K. 2002. Finite Element Analysis of Transient Contaminant Transport: A Stochastic Approach. T ASAE, 45:2049-59.
3. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. 2002. Nanocrystal targeting in vivo. PNAS %R 10.1073/pnas.152463399, 99:12617-21.
4. Anderson RJ. 2002.20/20 Vision: A brave new world of drug development. Curr Drug Discov, August: 25-9.
5. Atluri SN, Shen S. 2002. The meshless local petrov-galerkin (MLPG) method: A simple and less-costly alternative to the Finite Element and Boundary Element methods. Comput Modeling Eng Sci, 3:11-52.
6. Bhalgat MK, Roberts JC. 2000. Molecular modeling of polyamidoamine (PAMAM) Starburst(TM) dendrimers. Eur Polym J, 36:647-51.
7. Boobis A, Gundert-Remy U, Kremers P, et al. 2002. In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15. Eur J Pharm Sci, 17:183-93.
8. Cagin T, Wang G, Martin R, et al. 2001. Multiscale modeling and simulation methods with applications to dendritic polymers. Comput Theor Polym, S 11:345-56.
9. Chen W, Fish J. 2006. A generalized space-time mathematical homogenization theory for bridging atomistic and continuum scales. International Journal for Numerical Methods in Engineering, 67:253-71.
10. Clement R, Jonquieres A, Sarti I, et al. 2004. Original structure-property relationships derived from a new modeling of diffusion of pure solvents through polymer membranes. J Membrane Sci, 232:141-52.
11. Costa P, Sousa L, Jose M. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123-33.
12. Dawson M, Krauland E, Wirtz D, et al. 2004. Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnology Progress, 20:851-7.
13. Donea J, Huerta A, Ponthot J-P, et al 2004. Arbitrary lagrangian-eulerian methods (Chapter 14). In Encyclopedia of Computational Mechanics, Volume 1: Fundamentals., ed. E Stein, dB R., H T.J.R. New York: John Wiley & Sons, Ltd.
14. Dresco PA, Zaitsev VS, Gambino RJ, et al. 1999. Preparation and properties of magnetite and polymer magnetite nanoparticles. Langmuir, 15:1945-51.
15. Eliaz RE, Nir S, Szoka J, Francis C. 2004. Interactions of hyaluronan-targeted liposomes with cultured cells: modeling of binding and Endocytosis. Methods in Enzymology. In Liposomes, Part D, ed. N Duzgunes, pp. 16-33: Academic Press.
16. Farokhzad OC, Cheng J, Teply BA, et al. 2006. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. PNAS, 103:6315-20.
17. Farokhzad OC, Khademhosseini A, Jon S, et al. 2005. Microfluidic system for studying the interaction of nanoparticles and microparticles with cells. Anal Chem, 77:5453-9.
18. Fast P, Shelley MJ. 2004. A moving overset grid method for interface dynamics applied to non-newtonian hele-shaw flow. J Comput Phys, 195:117-42.
19. Fish J, Chen W. 2004a. Discrete-to-continuum bridging based on multigrid principles. Comput Method Appl M, 193:1693-711.
20. Fish J, Chen W. 2004b. Discrete-to-continuum bridging based on multigrid principles. Computer Methods in Applied Mechanics and Engineering, 193:1693-711.
21. Fishman GS. 1996. Monte Carlo: Concepts, Algorithms and applications, New York: Springer Verlag. pp 698.
22. Flory PJ. 1953. Principles of Polymer Chemistry; Ithaca, NY: Cornell University.
23. Freund LB, Lin Y. 2004. The role of binder mobility in spontaneous adhesive contact and implications for cell adhesion. J Mech Phys Solids, 52:2455-72.
24. Gao H, Shi W, Freund LB. 2005. Mechanics of receptor-mediated endocytosis. P Natl Acad Sci, 102:9469-74.
25. Gex-Fabry M, DeLisi C. 1984. Receptor-mediated endocytosis: a model and its implications for experimental analysis. Am J Physiol, 247:R768-R79.
26. Ghanem RG, Kruger RM. 1996. Numerical solution of spectral stochastic finite element systems. Computer Methods in Applied Mechanics and Engineering, 129:289-303.
27. Ghoniem NM, Cho K. 2002. The emerging role of multiscale modeling in nano- and micro-Mechanics of materials. Comput Modeling Eng Sci, 3.
28. Gozalbes R, Doucet JP, Derouin F. 2002. Application of Topological Descriptors in QSAR and Drug Design: History and New Trends. Curr Drug Targets: Infect Disord, 2:93-102.
29. Grasela T, Fiedler-Kelly J, Walawander C, Owen J, Cirincione B, et al. 2005. Challenges in the Transition to Model-Based Development. AAPS J, 07:E488-E95.
30. Grass GM. 1997. Simulation models to predict oral drug absorption from in vitro data. Adv Drug Deliver Rev, 23:199-219.
31. Greene N. 2002. Computer systems for the prediction of toxicity: an update. Adv Drug Deliver Rev, 54:417-31.
32. Gref R, Minamitake Y, Peracchia MT, et al. 1994. Biodegradable Long-Circulating Polymeric Nanospheres. Science, 263:1600-3.
33. Gueyffier D, Li J, Nadim A, et al. 1999. Volume-of-fluid interface tracking with smoothed surface stress methods for three-dimensional flows. J Comput Phys, 152:423-56.
34. Haddish-Berhane N, Farhadi A, Nyquist C, et al. 2006a. Biological variability and targeted delivery of therapeutics for Inflammatory Bowel Diseases: an in silico approach. Inflammation & Allergy - Drug Targets, Submitted.
35. Haddish-Berhane N, Nyquist C, Haghighi K, et al. 2006b. A multi-scale stochastic drug release model for polymer-coated targeted drug delivery systems. J Control Release, 110:314-22.
36. Hirt CW, Nichols BD. 1981. Volume of fluid (VOF) method for the dynamics of free boundaries. J Comput Phys, 39:201-25.
37. Kane JH. 1993. Boundary element analysis in engineering continuum mechanics. Englewood Cliffs, NJ: Prentice-Hall.
38. Kanjickal DG, Lopina ST. 2004. Modeling of drug release from polymeric delivery systems - a review. Crit Rev Ther Drug, 21:245-386.
39. Karelson M. 2000. Molecular Descriptors in QSAR/QSPR. New York: J. Wiley & Sons.
40. Karelson M, Lobanov VS, Katritzky AR. 1996. Quantum-Chemical Descriptors in QSAR/QSPR Studies. Chem Rev, 96:1027-44.
41. Karelson M, Maran U, Wang Y, et al. 1999. QSPR and QSAR models derived using large molecular descriptor spaces. A review of CODESSA applications. Collect Czech Chem Commun, 64:1551-71.
42. Katritzky AR, Ignatchenko ES, Barcock RA, et al. 1994. Prediction of gas chromatographic retention times and response factors using a general qualitative structure-property relationships Treatment. Anal Chem, 1799-1807.
43. Katritzky AR, Maran U, Karelson M, et al. 1997. Prediction of melting points for the substituted benzenes: A QSPR Approach. J Chem Inf Comput Sci, 37:913-9.
44. Katritzky AR, Rachwal P, Law KW, et al. 1996. Prediction of Polymer Glass Transition Temperatures Using a General Quantitative Structure-Property Relationship Treatment. J Chem Inf Comput Sci, 36:879-84.
45. Kawasaki ES, Player A. 2005. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine, 1:101-9.
46. Kennedy T. 1997. Managing the drug discovery/development interface. Drug Discovery Today, 2:436-44.
47. Kenneth D, Charles S, Kevin L, et al. 2005. Epithelial internalization of superparamagnetic nanoparticles and response to external magnetic field. Biomaterials, 26:2061-72.
48. Khaled A, Guo S, Li F, et al. 2005. Controllable Self-Assembly of Nanoparticles for Specific Delivery of Multiple Therapeutic Molecules to Cancer Cells Using RNA Nanotechnology. Nano Letters, 5:1797-808.
49. Kitchens KM, El-Sayed MEH, Ghandehari H. 2005. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliver Rev, 57:2163-76.
50. Knobbe EM. 2004. A FEM-ALE approach for continuous domains with arbitrary moving boundaries. Presented at European congress on computational methods in applied sciences and engineering ECCOMAS 2004, Jyvaskyla.
51. Kubinyi H. 2004. Validation and predictivity of QSAR models. Presented at 15th EURO-QSAR Symposium, Istanbul, Turkey.
52. Langer R, Peppas NA. 1983. Chemical and physical structure of polymers as carriers for controlled release of bioactive agents: a review. J Macromol Sci Rev Macromol Chem Phys, C23:61-126.
53. Lauffenburger DA, Linderman JJ. 1993. Receptors: Models for binding, Trafficking and signaling. New York: Oxford University Press (Chapter 3).
54. LeVeque JR. 2002. Finite volume methods for hyperbolic problems. Cambridge: Cambridge University Press. pp. 578.
55. Lewis JD, Destito G, Zijlstra A, et al. 2006. Viral nanoparticles as tools for intravital vascular imaging. Nature Medicine, 12:354-06.
56. Li J, Hesse M, Ziegler J, et al. 2005. An arbitrary lagrangian eulerian method for moving-boundary problems and its application to jumping over water. J Comput Phys, 208:289-314.
57. Lindahl EBH, van der Spoel D. 2001. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Model, 7:306-17.
58. Maiti A, Wescott J, Goldbeck-Wood G. 2004. Mesoscale modelling: recent developments and applications to nanocomposites, drug delivery and precipitation membranes. Int J Nanotechnology, 2:198-214.
59. Manjunath K, Venkateswarlu V. 2005. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduedenal administration. Journal of Controlled Release, 107:215-28.
60. Mansfield ML, Klushin LI. 1993. Monte carlo studies of dendrimer macromolecules. Macromolecules, 26:4262-8.
61. Maury B. 1999. Direct simulations of 2D fluid-particle flows in biperiodic domains. J Comput Phys, 156:325-51.
62. McCarthy JR, Perez JM, Bruckner C, et al. 2005. Polymeric nanoparticle preparation that eradicates tumors. Nano Letters, 5:2552-6.
63. Melsa JL, Sage AP. 1973. An introduction to probability and stochastic processes. New Jersy: Prentice-Hall.
64. Munack A. 1989. Optimal feeding strategy for identification of monod-type models by fed-batch experiments. In Computer applications in fermentation technology, modelling and control of biotechnological process, ed. NM Fish, RI Fox, NF Thomhill, pp. 195-204. Amsterdam: Elsevier.
65. Nahor HB, Scheerlinck N, Verniest R, et al. 2001. Optimal experimental design for the parameter estimation of conduction heated foods. Journal of Food Engineering, 48:109-19.
66. Naylor AM, Goddard III WA, Kiefer GE, et al. 1989. Starburst dendrimers. Part V: Molecular shape control. J Am Chem Soc, 111:2339-41.
67. Neumann D, Lehr C-M, Lenhof H-P, et al. 2004. Computational modeling of the sugar-lectin interaction. Adv Drug Deliver Rev, 56:437-57.
68. Nicolai BM, Baerdemaeker JD. 1997. Finite element perturbation analysis of non-linear heat coduction with random field parameters. Int J Numer Method H, 7:525-44.
69. Nicolai BM, Baerdemaeker JD. 1999. A variance propagation algorithm for the computation of heat conduction under stochastic conditions. Int J Heat Mass Transfer, 42:1513-20.
70. Nithiarasu P. 2005. An arbitrary lagrangian eulerian (ALE) formulation for free surface flows using the characterstic-based split (CBS) scheme. Int J Numer Meth Fl, 48:1415-28.
71. Nunes-Correia I, Ramalho-Santos J, Nir S, et al. 1999. Interactions of influenza virus with cultured cells: Detailed kinetic modeling of binding and endocytosis. Biochemistry, 38:1095-101.
72. Oberdorster G, Maynard A, Donaldson K, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology, 2:1-35.
73. Popielarski SR, Hu-Lieskovan S, French SW, et al. 2005. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the Liver 2. In Vitro and In Vivo Uptake Results. Bioconjugate Chem, 16:1071-80.
74. Popinet S, Zaleski S. 1999. A front-tracking algorithm for accurate representation of surface tension. Int J Numer Meth Fl, 30:775-93.
75. Prow TW, Rose WA, Wang N, et al. 2005. Biosensor-Controlled Gene Therapy/ Drug Delivery with Nanoparticles for Nanomedicine. Proc SPIE, 5692:199-208.
76. Quintana A, Raczka E, Piehler L, et al. 2002. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells Through the folate receptor. Pharm Res, 19:1310-b.
77. Reddy JN. 2005. An introduction to the finite element method. New York: McGraw-Hill Book Co.
78. Reddy MR, Erion MD, eds. 2001. Free energy calculations in rational drug design. New York: Springer-Verlag.
79. Reddy MR, Erion MD, A.A. 2000. Free energy calculations: Use and limitations in predicting ligand binding affinities. In Reviews in Computational Chemistry, pp. 217-304. New York: VCH Publishers.
80. Renardy Y, Renardy M. 2002. PROST: A parabolic reconstruction of surface tension for the volume-of-fluid method. J Comput Phys, 183:400-21.
81. Rhodes CT, Porter CS. 1998. Coatings for controlled release drug delivery systems. Drug Dev Ind Pharm, 24:1139-54.
82. Rolland JP, Maynor BW, Euliss LE, et al. 2005. Direct fabrication and harvesting of monodisperse shape-specific nanobiomaterials. Journal of the American Chemical Society, 127:10096-100.
83. Russell-Jones GJ, Veitch H, Arthur L. 1999. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int J Pharm, 190:165-74.
84. Ryskin G, Leal LG. 1984. Numerical solution of free-boundary problems in fluid mechanics. Part 2: Buoyancy-driven motion of a gas bubble through a quiescent liquid. J Fluid Mech, 148:19-36.
85. Rytting E, Lentz KA, Chen X-Q, et al. 2004. A quantitative structure-property relationship for predicting drug solubility in PEG 400/Water cosolvent systems. Pharm Res, 21:237-44.
86. Scardovelli R, Zaleski S. 1999. Direct numerical simulation of free surface and interfacial flow. Ann Rev Fluid Mech, 31:567-604.
87. Scheerlinck N, Verboven P, Stigter JD, et al. 2001. A variance propagation algorithm for stochastic heat and mass transfer problems in food processes. Int J Numer Meth Eng, 51:961-83.
88. Schuttelkopf AW, van Aalten DMF. 2004. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D, 60:1355-63.
89. Segerlind LJ. 1984. Applied finite element analysis. New York: Wiley.
90. Shephard MS. 2004. Adaptive discretization and modeling. In Final report: second DOE workshop on multiscale problems, ed. D Estep, JN Shadid, D Zachmann, pp. 52. Broomsfield, Colorado: Department of energy
91. Shimizu A, Kawashima S. 1989. Kinetic study of internalization and degradation of I-labeled follicle-stimulating hormone in mouse Sertoli cells and its relevance to other systems. J Biol Chem, 264:13632-8.
92. Siepmann J, Gopferich A. 2001. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliver Rev, 48:229-47.
93. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliver Rev, 48:139-57.
94. Sun X, Rossin R, Turner JL, et al. 2005. An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PE-Gylation on in vivo biodistribution. Biomacromolecules, 6:2541-54.
95. Thurmond KBI, Kowalewski T, Wooley KL. 1996. Water-Soluble Knedel-like Structures: The preparation of shell-cross-linked small particles. J Am Chem Soc, 118:7239-40.
96. Tryggvason G, Unverdi SO. 1990. Computations of three-dimensional rayleigh-taylor instability. Phys Fluids A-Fluid, 2:656-9.
97. Tzafriri AR, Wu D, Edelman ER. 2004. Analysis of compartmental models of ligand-induced endocytosis. J Theor Biol, 229:127-38.
98. Unverdi SO, Tryggvason G. 1992. A front-tracking method for viscous, incompressible, multi-fluid flows. J Comput Phys, 100:25-37.
99. van de Waterbeemd H, Gifford E. 2003. ADMET in silico modeling: Towards prediction paradise? Nat Rev Drug Discov, 2:192-204.
100. Webster TJ. 2006. Welcome to the international journey to improving human health. Int J Nanomedicine, 1:1-2.
101. Wiley HS, Cunningham DD. 1981. A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands. Cell, 25:433-40.
102. Wiley HS, Cunningham DD. 1982. The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis. J Biol Chem, 257:4222-9.
103. Zigmond S, Sullivan S, Lauffenburger D. 1982. Kinetic analysis of chemotactic peptide receptor modulation. J Cell Biol, 92:34-43.